Scientific article
English

Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials

Published in

Clinical microbiology and infection, vol. 9, no. 9, p. 949-954

Publication date

2003

Abstract

In order to determine the causes of treatment failure in community-acquired pneumonia (CAP) clinical trials, a MEDLINE search for all CAP studies published between 1990 and 1997 was performed. Prospective, randomized studies comparing the efficacy of two or more antibiotics in CAP were selected. Treatment failure was defined as persistent fever, deterioration of patient's condition, or a change in the prescribed antibiotic regimen. In 16% of the cases included in the clinical trials, the treatment of CAP is unsuccessful. A significant number of identified failure cases were owing to antibiotic side-effects. Resistant pathogens are an unusual cause of failure whatever the antibiotic used.

Keywords

  • Aged
  • Anti-Bacterial Agents/ therapeutic use
  • Community-Acquired Infections/ drug therapy
  • Humans
  • Pneumonia/ drug therapy
  • Randomized Controlled Trials as Topic/ methods
  • Retrospective Studies
  • Treatment Failure

Citation (ISO format)

GENNE, Daniel et al. Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials. In: Clinical microbiology and infection, 2003, vol. 9, n° 9, p. 949–954.

Main files (1)

Article

Identifiers

Journal ISSN

1198-743X
602views
0downloads

Technical informations

Creation

21/06/2010 10:24:25

First validation

21/06/2010 10:24:25

Update

14/03/2023 15:43:49

Status update

14/03/2023 15:43:49

Last indexation

29/10/2024 15:11:09
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated